ModivCare Inc Sees $1.23m in Stock Purchases by Major Stakeholders
Barrington Maintains ModivCare(MODV.US) With Buy Rating, Maintains Target Price $25
ModivCare's Growth Potential and Asset Value Highlighted Amid Financial Restructuring: Buy Rating With $25 Price Target
Implied Volatility Surging for ModivCare (MODV) Stock Options
Top ModivCare Shareholder Grows Restless -- Market Talk
ModivCare, Inc. (MODV) Q3 2024 Earnings Call Transcript Summary
ModivCare Management to Meet With Barrington
ModivCare Is Maintained at Outperform by Barrington Research
ModivCare Analyst Ratings
Barrington Maintains ModivCare(MODV.US) With Buy Rating, Raises Target Price to $25
Deutsche Bank Maintains ModivCare(MODV.US) With Hold Rating, Cuts Target Price to $18
ModivCare Price Target Lowered to $18 From $26 at Deutsche Bank
Modivcare Inc. Faces Financial Uncertainty Amid Extended Payor Delays and Liquidity Concerns
Modivcare Inc. Reports Q3 2024 Financial Results
ModivCare | 10-Q: Q3 2024 Earnings Report
Lake Street Maintains ModivCare(MODV.US) With Buy Rating, Maintains Target Price $30
ModivCare (MODV) Receives a Buy From Lake Street
Express News | ModivCare Inc: Qtrly Shr Loss $1.87
Express News | ModivCare Affirms FY2024 Sales Guidance to $2.70B-2.90B VS Est.2.82B
Earnings Flash (MODV) MODIVCARE Posts Q3 Revenue $702M
No Data
No Data